Fuji Pharma Co., Ltd. (FRA:FUP)

Market Cap	238.90M
Revenue (ttm)	297.62M
Net Income (ttm)	17.28M
Shares Out	n/a
EPS (ttm)	0.71
PE Ratio	13.83
Forward PE	n/a
Dividend	0.27 (2.78%)
Ex-Dividend Date	Sep 29, 2025

Volume	n/a
Average Volume	14
Open	9.70
Previous Close	9.65
Day's Range	9.70 - 9.70
52-Week Range	7.25 - 10.30
Beta	n/a
RSI	65.71
Earnings Date	Nov 11, 2025

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, as well as information regarding pharmaceuticals and health; and contract manufacturing services. Fuji Pharma Co., Ltd. was founded in 1959 and is headquartered in Tokyo, Japan.

• Industry: Pharmaceutical Preparations
• Founded: 1959
• Employees: 1,658
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FUP

Financial Performance

In 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.

Financial numbers in JPY